Nutritional and Exercise Intervention in Older Adults Admitted to the Acute Care Unit (SERIA) (SERIA)

Hyperproteic Oral Supplementation With Vitamin D and Resistance Training in Older Patients Admitted to the Acute Unit (SERIA)

This is a randomised, parallel, single-blind clinical trial. Objectives: to evaluate: the impact of the intervention on nutritional status, body composition, strength, the prevalence of sarcopenia and physical performance at discharge and three months later..

Study Overview

Detailed Description

Design: A randomised controlled clinical trial with four parallel groups is being conducted with older adults admitted to an acute geriatric unit at risk of malnutrition or with malnutrition. The participants are randomly assigned to one of the groups. Three assessment visits are being conducted: at admission, discharge, and three months later.

Setting: The study is being conducted in the Unidad de Agudos del Servicio de Geriatría at Hospital Universitario Ramón y Cajal, by the Servicio Madrileño de Salud (SERMAS).

Interventions: four groups: 1) a resistance training group (RT); 2) an oral nutritional supplementation group (ONS); 3) a combination of RT and ONS (RT+ONS); and a control group (CG). The patients in the RT group follow individualized RT sessions with a physiotherapist daily during the hospitalization and three weekly home sessions on their own after discharge. The sessions are structured according to the recommendations of the American College of Sports Medicine (ACSM), mainly RT.

Study population: A study of malnourished or at-risk outpatients in our setting was used to calculate the sample size. In that study, with an alpha error of 0.05 and a beta of 0.80, the minimum sample size was 14 participants per group. Our objective is to include, at least, 21 participants per group, resulting in a total of 84 participants.

Sociodemographic and clinical variables are being collected (e.g., age, sex, living situation, number of drugs, falls). Information about nutritional and functional status (e.g., MNA, gait speed, Barthel, Lawton, and FAC), body composition (e.g., weight, height, body mass index, appendicular muscle mass index measured by bioimpedanciometry (BIA)), ultrasound measurements of the anterior rectus (area, thickness, and penation angle), and muscle strength (hand grip test) is also collected.

The first descriptive analysis of the variables will include frequencies and percentages for categorical variables and means and standard deviations for continuous variables. Changes in nutritional status will be analysed as well as the interaction between nutrition and exercise by repeated measures ANOVA. The prevalence of sarcopenia and the influence of each component of the sarcopenia definition on physical performance, ADLs, emergency room visits, and new admissions. Additionally, a survival analysis will be performed to compare the four groups. To assess the quality of ultrasound measurement, the relationship between each ultrasound variable and the bioimpedance score, as well as the diagnostic criteria for malnutrition and sarcopenia, will be analysed. Furthermore, ultrasound measurements will be correlated with the estimation of muscle mass using bioimpedance analysis. A p-value less than 0.05 will be considered statistically significant.

The study is being conducted under the ethical standards set forth by the Comité de Ética de Investigación con Medicamentos (CEIm) of the Hospital Universitario Ramón y Cajal. Each participant is informed about the study and signs the informed consent before inclusion. The study has been designed and subsequently evaluated under Law 14/2007 on Biomedical Research, the ethical principles of the Declaration of Helsinki of the World Medical Association on Ethical Principles for Medical Research on Human Beings, as well as the other ethical principles and legal regulations applicable according to the characteristics of the study.

Study Type

Interventional

Enrollment (Actual)

105

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Madrid, Spain, 28034
        • Hospital Universitario Ramon y Cajal

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

Patients admitted to the Unidad de Agudos (Geriatric Acute Care) del Servicio de Geriatría at HU Ramón y Cajal who are at risk of malnutrition or malnutrition (defined with a MNA-SF score ≤ 11) and who sign the informed consent form.

Exclusion Criteria:

  • patients with estimated discharge within 72 hours.
  • Re-admissions (defined as previous admission in the Geriatric Acute Care in the last 3 months)
  • Patients taking ONS for more than two weeks.at the time of admission.
  • Patients suffering any illness or condition that prevents or contraindicates resistance physical exercise. and oral food intake.
  • Food allergies or intolerances that contraindicate the SNO.
  • Patients with advanced dementia (GDS stage 7) or palliative care.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Resistance Training (RT)
They are performing programmed physical exercise started on the day of admission, focusing on muscle strength gain, and they are being taught how to continue exercising three times a week after discharge from hospital. Lower limb strength exercises (squats and knee extensions) and upper limb strength exercises (elbow flexion, lateral and frontal raises, and tractions) were performed. A progression of the load are being made by increasing one set per month and 2 to 4 repetitions per month depending on the patient's capabilities.
Resistance training for elderly patients in the acute care unit.
Other Names:
  • RT
Experimental: Oral Nutritional Supplementation (ONS)
They are receiving a hypercaloric, hyperproteic, oral nutritional supplement with vitamin D and CaHMB (ß-hydroxy-ß-methylbutyrate) (Ensure Plus Advance®), at a dose of two packets per day in two or more doses for 3 months.
To receive two daily packs of a hypercaloric and hyperproteic oral nutritional supplement for 3 months.
Other Names:
  • ONS
Sham Comparator: Control Group (CG)
They are being treated according to standard clinical practice, which includes information from the health professionals on the ward on recommended dietary and exercise guidelines. When the treating team considers the use of an oral nutritional supplement to be indicated, it is being prescribed.
No intervention
Other Names:
  • CG
Experimental: Resistance Training (RT) and Oral Nutritional Supplementation (ONS)
They receive joint treatment
Resistance training for elderly patients in the acute care unit.
Other Names:
  • RT
To receive two daily packs of a hypercaloric and hyperproteic oral nutritional supplement for 3 months.
Other Names:
  • ONS

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mini Nutritional Assessment (MNA)
Time Frame: 12 weeks
Screening tool to help identify malnourished elderly people or those at risk of malnutrition on a scale of 0 to 30. The higher the value, the better the nutritional status of the older adult.
12 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Hand grip test
Time Frame: 12 weeks
Measurement of hand grip strength using a hand-held dynamometer.
12 weeks
Body Mass Index (BMI)
Time Frame: 12 weeks
Is a mathematical ratio that associates the mass and the size of an individual BMI = weight / height ^2
12 weeks
Appendicular Skeletal Muscle mass Index (ASMI)
Time Frame: 12 weeks
It is the sum of muscle masses of the four limbs measured with BIA.
12 weeks
4-m-test
Time Frame: 12 weeks
It consists of assessing the patient's usual walking speed over a distance of 4 metres.
12 weeks
Barthel's index
Time Frame: 12 weeks
Test to assess the patient's ability to perform basic activities of daily living on a scale of 0 to 100. The higher the value, the greater the independence of the older adult.
12 weeks
Lawton-Brody scale
Time Frame: 12 weeks
Test to assess the patient's ability to perform instrumental activities of daily living on a scale of 0 to 8. The higher the score, the greater the functional capacity of the older adult.
12 weeks
Functional Ambulation Classification (FAC)
Time Frame: 12 weeks
Test to assess a person's ability to walk with a score from 0 to 5. The higher the score, the greater the walking independence.
12 weeks
Thickness
Time Frame: 12 weeks
An ultrasound is performed in the middle of the anterior rectus, measuring from the patella to the anteroinferior iliac spine. Through a cross section the image is frozen and a straight line of the thickness of the center of the anterior rectus is drawn at that point. The distance is noted in mm.
12 weeks
Penile angle of a muscle
Time Frame: 12 weeks
An ultrasound is performed in the middle of the anterior rectus, measuring from the patella to the anteroinferior iliac spine. Unlike the other measurements, the ultrasound image is taken in the longitudinal section. The penile angle of a muscle is the orientation of the muscle fibers in relation to the connective tissue/tendon. It is taken by fixing one side of the angle on the connective tissue and the other side on the orientation of the muscle fibers. The value is noted in degrees.
12 weeks
Cross-sectional area
Time Frame: 12 weeks
An ultrasound is performed in the middle of the anterior rectus, measuring from the patella to the anteroinferior iliac spine. Through a cross section the image is frozen and the area of the volume of the anterior rectum at that point is traced. The area is noted in cm^2.
12 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Beatriz Montero-Errasquín, Dra., Hospital Ramon y Cajal.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 11, 2023

Primary Completion (Actual)

January 30, 2025

Study Completion (Actual)

June 30, 2025

Study Registration Dates

First Submitted

September 4, 2024

First Submitted That Met QC Criteria

September 19, 2024

First Posted (Actual)

September 23, 2024

Study Record Updates

Last Update Posted (Actual)

August 7, 2025

Last Update Submitted That Met QC Criteria

August 5, 2025

Last Verified

August 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

No personal information will be shared. At the time of enrolment, each participant will be given a code. The full database of outcome variables will also not be shared.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Sarcopenia

Clinical Trials on Control Group

Subscribe